Skip to main content
    C

    Creative Medical Technology Holdings Inc (CELZ)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.52
    -0.01 (-1.51%)

    Market Cap: $4.01M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Creative Medical Technology Holdings Inc (CELZ) Financials: Revenue, Profit and Cash Flow

    Updated Nov 6, 2026. Financial statements from company filings, amounts in US dollars.

    Creative Medical Technology Holdings reported revenue of $6.00K for the fiscal year ended Dec 31, 2025, down 45.5% from the year before. That year, net income was -$6.00M with a net margin of -99916.8%, operating cash flow was -$5.86M and free cash flow was -$5.86M. The quarter ended Sep 30, 2026 had revenue of $0 and net income of -$2.66M.

    Revenue and Margins

    Over the 8 years to Dec 2025, revenue grew from $4.80K, a compound annual rate of 2.8%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$6.00K-45.5%63.4%-102380.2%-99916.8%
    Dec 2024$11.00K+22.2%60.0%-52216.9%-49940.7%
    Dec 2023$9.00K-89.8%60.0%-62445.9%-58739.7%
    Dec 2022$88.60K+1.0%67.8%-11562.5%-11449.3%
    Dec 2021$87.75K-46.7%45.4%-3562.2%21892.8%
    Dec 2020$164.50K-0.6%69.2%-677.7%-22082.2%
    Dec 2019$165.50K+33.0%72.5%-682.9%-5126.1%
    Dec 2018$124.40K+2491.7%43.4%-895.7%-10977.2%
    Dec 2017$4.80KN/A-66.7%-24537.6%-55398.1%
    Dec 2016$0N/AN/AN/AN/A
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$6.00K$11.00K$9.00K$88.60K$87.75K$164.50K$165.50K$124.40K$4.80K$0
    Cost of revenue$2.19K$4.40K$3.60K$28.49K$47.95K$50.60K$45.50K$70.38K$8.00K$0
    Gross profit$3.81K$6.60K$5.40K$60.11K$39.80K$113.90K$120.00K$54.02K-$3.20K$0
    Research and development$2.26M$2.40M$1.97M$6.27M$109.18K$0$0$96.62K$260.08K$85.33K
    Operating income-$6.14M-$5.74M-$5.62M-$10.24M-$3.13M-$1.11M-$1.13M-$1.11M-$1.18M-$759.67K
    Net income-$6.00M-$5.49M-$5.29M-$10.14M$19.21M-$36.33M-$8.48M-$13.66M-$2.66M-$766.07K
    EBITDA-$6.02M-$5.63M-$5.53M-$10.15M$27.74MN/AN/AN/AN/A-$750.32K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$0$0$0$3.00K$0$0$3.00K$3.00K$0$8.00K$0$3.00K
    Gross profit$0$0$0$2.01K$0$0$1.80K$1.80K$0$4.80K$0$1.80K
    Operating income-$2.73M-$1.56M-$1.46M-$1.95M-$1.27M-$1.26M-$1.66M-$1.89M-$1.11M-$1.63M-$1.12M-$1.77M
    Net income-$2.66M-$1.51M-$1.40M-$1.89M-$1.24M-$1.23M-$1.64M-$1.85M-$1.04M-$1.56M-$1.04M-$1.68M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents of $7.21M were 92.3% of total assets of $7.81M, against total liabilities of $284.88K.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$7.81M$6.67M$10.72M$19.19M$11.27M$717.77K$530.80K$477.16K$203.15K$322.51K
    Current assets$7.40M$6.14M$10.27M$18.75M$10.74M$98.01K$94.25K$313.66K$18.50K$221.87K
    Cash and equivalents$7.21M$5.94M$3.47M$8.32M$10.72M$98.01K$88.65K$304.06K$13.70K$221.87K
    Total liabilities$284.88K$327.64K$371.39K$3.32M$1.05M$40.52M$8.60M$4.47M$2.44M$480.30K
    Short-term debtN/A$14.19K$14.19K$14.19K$14.19K$788.70K$1.06M$682.06K$501.75K$100.00K
    Long-term debtN/AN/AN/AN/AN/AN/AN/AN/A$915$25.00K
    Shareholder equity$7.51M$6.34M$10.34M$15.86M$10.22M-$39.80M-$8.07M-$3.99M-$2.24M-$157.79K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$7.28M$9.38M$6.44M$7.81M$5.85M$7.11M$8.35M$6.67M$6.89M$7.99M$9.62M$10.72M
    Total liabilities$293.23K$698.60K$307.65K$284.88K$261.35K$277.64K$286.39K$327.64K$330.91K$376.27K$390.96K$371.39K
    Cash and equivalents$6.85M$8.71M$5.72M$7.21M$5.38M$6.54M$7.70M$5.94M$6.26M$7.47M$9.01M$3.47M
    Shareholder equity$6.95M$8.65M$6.11M$7.51M$5.59M$6.83M$8.06M$6.34M$6.56M$7.61M$9.23M$10.34M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$5.86M-$5.30M-$8.03M-$7.80M-$2.22M-$434.56K-$1.21M-$1.05M-$889.62K-$445.23K
    Capital expenditures$5$200.00K$100.00K$4$0$250.00K$3$0$0$10.00K
    Free cash flow-$5.86M-$5.50M-$8.13M-$7.80M-$2.22M-$684.56K-$1.21M-$1.05M-$889.62K-$455.23K
    Dividends paidN/AN/AN/AN/A$4.78MN/AN/AN/AN/AN/A
    Share repurchases$10.00K$174.96K$270.95K$0N/A$0N/AN/AN/AN/A
    Investing cash flow-$50.50K$6.32M$3.45M-$10.08M$0-$250.00K$0$0$0-$10.00K
    Financing cash flow$7.17M$1.45M-$270.95K$15.47M$12.84M$693.92K$997.68K$1.34M$681.45K$677.00K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$1.66M-$1.47M-$1.32M-$1.94M-$1.17M-$1.16M-$1.59M-$1.95M-$985.59K-$1.47M-$896.86K-$1.89M
    Capital expendituresN/AN/A$125.00K$4$0$3$0$0$2$4$4$100.00K
    Free cash flowN/AN/A-$1.45M-$1.94M-$1.17M-$1.16M-$1.59M-$1.95M-$985.59K-$1.47M-$896.87K-$1.99M
    Last 12 quarters

    Frequently Asked Questions About CELZ

    What is Creative Medical Technology Holdings' annual revenue?

    Creative Medical Technology Holdings reported revenue of $6.00K for the fiscal year ended Dec 31, 2025.

    How fast is Creative Medical Technology Holdings' revenue growing?

    Revenue was down 45.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -59.2%.

    Is Creative Medical Technology Holdings profitable?

    No. Creative Medical Technology Holdings reported net income of -$6.00M for the fiscal year ended Dec 31, 2025, with a net margin of -99916.8%.

    How much free cash flow does CELZ generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$5.86M minus capital expenditures of $5 produced free cash flow of -$5.86M.

    How much debt does Creative Medical Technology Holdings have?

    The balance sheet dated Dec 31, 2025 reported cash and equivalents of $7.21M.